Relevant bibliographies by topics / Bollette / Journal articles
To see the other types of publications on this topic, follow the link: Bollette.

Journal articles on the topic 'Bollette'

Author: Grafiati
Published: 1 April 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Bollette.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

van Drumpt, Majorie, Marlous Huijzer, Bob Bloemendaal, and Jolien van de Pol. "Een buik vol bolletjes." Critical Care 11, no. 1 (February 2014): 6–10. http://dx.doi.org/10.1007/s12426-014-0011-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Coletti, Vittorio. "Il prezzo può essere ivato." XII, 2020/1 (gennaio-marzo) 12, no. 1 (March 24, 2020): 68–69. http://dx.doi.org/10.35948/2532-9006/2020.3274.

Full text
Abstract:
Alcuni lettori ci hanno chiesto se usare ivato per indicare un prezzo o un prodotto il cui prezzo è comprensivo di IVA, o ivata riferito a una bolletta, sia “corretto” o non sia invece da considerarsi “osceno”.
APA, Harvard, Vancouver, ISO, and other styles
3

Ryskova, Lenka, Radka Bolehovska, Rudolf Kukla, Michal Svarc, Alzbeta Zavrelova, Hubert Vanicek, Ivo Pavlik, and Pavel Bostik. "Mycobacterioses Induced by Mycobacterium abscessus: Case Studies Indicating the Importance of Molecular Analysis for the Identification of Antibiotic Resistance." Antibiotics 11, no. 7 (June 28, 2022): 873. http://dx.doi.org/10.3390/antibiotics11070873.

Full text
Abstract:
Mycobacterioses are less frequently occurring but serious diseases. In recent years, at a global level, the incidence of mycobacterioses induced by the rapidly growing species Mycobacterium abscessus (M. a.), which is considered to be the most resistant to antibiotics and most difficult to treat, has been on the rise. Correct identification to the level of the subspecies (M. a. abscessus, M. a. massiliense, and M. a. bolletii) and determination of its sensitivity to macrolides, which are the basis of combination therapy, are of principal importance for the management of the disease. We describe five cases of mycobacterioses caused by M. a., where the sequencing of select genes was performed to identify the individual subspecies and antibiotic resistance. The analysis of the rpoB gene showed two isolates each of M. a. abscessus and M. a. massiliense and one isolate of M. a. bolletii. The complete (full length) erm(41) gene responsible for the development of inducible resistance to macrolides was demonstrated in both M. a. abscessus and M. a. bolletii isolates. A partially deleted and non-functional erm(41) gene was demonstrated in M. a. massiliense isolates. The subsequent sequencing of the full length erm(41) gene products showed, however, the mutation (T28→C) in both isolates of M. a. abscessus, causing a loss of the function and preserved sensitivity to macrolides. The antibiotic sensitivity testing confirmed that both the isolates of M. a. abscessus and M. a. massiliense were sensitive to clarithromycin even after prolonged 14-day incubation. The inducible resistance to clarithromycin was maintained only in M. a. bolletii. Thus, the sequence analysis of the erm(41) gene can reliably identify the preservation of sensitivity to macrolides and serve as an important tool in the establishment of therapeutic regimens in cases of infections with M. abscessus.
APA, Harvard, Vancouver, ISO, and other styles
4

Fleischer, Soraya, Raquel Lustosa da Costa Alves, Rosamaria Giatti Carneiro, Camila Vaz Neto Ferreira Correia, and Júlia Vilela Garcia. "COMO FAZER PESQUISA ANTROPÓLOGICA DURANTE A PANDEMIA DO COVID-19?" Revista Pós Ciências Sociais 19, no. 2 (June 30, 2022): 247–434. http://dx.doi.org/10.18764/2236-9473v19n2.2022.20.

Full text
Abstract:
Resenha sobre o livro: Etnografando na pandemia organizado por Paride Bollettin, Guillermo Vega Sanabria e Fátima Tavares.Disponível em: https://www.cleup.it/product/22390172/etnografando-na-pandemia.
APA, Harvard, Vancouver, ISO, and other styles
5

Rollet-Cohen, Virginie, Anne-Laure Roux, Muriel Le Bourgeois, Guillaume Sapriel, Manele El Bahri, Jean-Philippe Jais, Beate Heym, et al. "Mycobacterium bolletii Lung Disease in Cystic Fibrosis." Chest 156, no. 2 (August 2019): 247–54. http://dx.doi.org/10.1016/j.chest.2019.03.019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Henao-Martínez, Andrés F., Nancy Olague, and Carlos Franco-Paredes. "Spontaneous Mycobacterium bolletti skin abscesses — An underrecognized zoonosis from raw bovine milk." Travel Medicine and Infectious Disease 22 (March 2018): 77–78. http://dx.doi.org/10.1016/j.tmaid.2018.01.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Joseph, C., C. Petit, J. L. Schmit, M. Drancourt, E. Pluquet, and J. P. Lanoix. "Community-acquired granulomatous mastitis superinfected with Mycobacterium bolletii." Médecine et Maladies Infectieuses 50, no. 3 (May 2020): 291–92. http://dx.doi.org/10.1016/j.medmal.2019.11.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Choi, G. E., Y. J. Cho, W. J. Koh, J. Chun, S. N. Cho, and S. J. Shin. "Draft Genome Sequence of Mycobacterium abscessus subsp. bolletii BDT." Journal of Bacteriology 194, no. 10 (April 24, 2012): 2756–57. http://dx.doi.org/10.1128/jb.00354-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wertman, Rebecca, Melissa Miller, Pamela Groben, Dean S. Morrell, and Donna A. Culton. "Mycobacterium bolletii/Mycobacterium massiliense Furunculosis Associated With Pedicure Footbaths." Archives of Dermatology 147, no. 4 (April 11, 2011): 454. http://dx.doi.org/10.1001/archdermatol.2011.58.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

van Dijk, Theon. "Het CBb komt er uit voor Bolletje-beschuit: ACM bakt het al te bruin." Markt en Mededinging 19, no. 5 (November 2016): 209–15. http://dx.doi.org/10.5553/menm/138762362016019005007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Nunes, Luciana de S., Ludmila F. Baethgen, Marta O. Ribeiro, Cássia M. Cardoso, Fernanda de Paris, Simone M. M. De David, Marlei G. da Silva, Rafael S. Duarte, and Afonso L. Barth. "Outbreaks due to Mycobacterium abscessus subsp. bolletii in southern Brazil: persistence of a single clone from 2007 to 2011." Journal of Medical Microbiology 63, no. 10 (October 1, 2014): 1288–93. http://dx.doi.org/10.1099/jmm.0.074906-0.

Full text
Abstract:
Outbreaks associated with rapidly growing mycobacteria (RGM) have been increasingly reported worldwide, including in Brazil. Among the RGM, the Mycobacterium abscessus complex is the most pathogenic and related to multidrug resistance. The aim of this study was to evaluate the antimicrobial susceptibility and molecular profile of RGM isolates involved in new postsurgical infection outbreaks in Brazil since 2007. Of the 109 cases reported in the state of Rio Grande do Sul between 2007 and 2011, 43 (39 %) had confirmed mycobacterial growth in culture. Clinical isolates were obtained from biopsy specimens or abscess aspirates. PRA-hsp65 restriction pattern identified the isolates as M. abscessus type 2, and partial rpoB sequencing confirmed the identification as M. abscessus subsp. bolletii. All isolates were susceptible to amikacin and resistant to ciprofloxacin, doxycycline, sulfamethoxazole, moxifloxacin and tobramycin. Most isolates (72 %) were fully susceptible to cefoxitin but six isolates (14 %) were fully resistant to clarithromycin. The latter differed from the susceptibility profiles of the previously described BRA100 clone from other Brazilian regions. Nevertheless, pulsed-field gel electrophoresis analysis revealed that these isolates belonged to a single BRA100 clone. In conclusion, our study reports the persistence of an emergent single and highly resistant clone of M. abscessus subsp. bolletii for several years even after national implementation of infection control measures.
APA, Harvard, Vancouver, ISO, and other styles
12

Al-Waili, N., B. Farber, L. Gellman, and D. Gadaleta. "Isolation of Mycobacterium bolletii from human omentum after laparoscopic gastric banding." Clinical Microbiology and Infection 16, no. 10 (October 2010): 1561–63. http://dx.doi.org/10.1111/j.1469-0691.2010.03173.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Travis, Skye R., Madeline R. Shay, and Matthew K. Thompson. "Kinetic Characterization of a Novel Fosfomycin Resistance Enzyme from Mycobacterium Bolletii." Biophysical Journal 116, no. 3 (February 2019): 51a. http://dx.doi.org/10.1016/j.bpj.2018.11.321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Koh, W. J., O. J. Kwon, N. Y. Lee, Y. H. Kook, H. K. Lee, and B. J. Kim. "First Case of Disseminated Mycobacterium bolletii Infection in a Young Adult Patient." Journal of Clinical Microbiology 47, no. 10 (August 12, 2009): 3362–66. http://dx.doi.org/10.1128/jcm.00592-09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Lee, M. R., H. Y. Tsai, A. Cheng, C. Y. Liu, Y. T. Huang, C. H. Liao, S. K. Liang, L. N. Lee, and P. R. Hsueh. "Otitis Media and Otomastoiditis Caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii)." Journal of Clinical Microbiology 50, no. 11 (August 29, 2012): 3754–56. http://dx.doi.org/10.1128/jcm.01049-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

della Redazione, A. cura. "Cartof Fierbinte - La Patata bollente! I confini tra competenze sociali e sanitarie e tra clinica e riabilitazione." MISSION, no. 57 (August 2022): 24–28. http://dx.doi.org/10.3280/mis57-2022oa14306.

Full text
Abstract:
Teo Vignoli, Miriam Savarese, Michela Tazzini, Stefano Aringhieri, Paola Avveduti, Giorgia Bondi, Monica Bosi, Simona Brunetti, Luigi Caputo, Gaetano Cerreto, Luigi De Donno, Sabrina Ferroni, Daniela Forlano, Giuseppa Ghetti, Cinzia Ghidoni, Daniele Innocenti, Giovanna Maria Latino, Mirta Malpassi, Andrea Martini, Elisa Martino, Antonella Monti, Angela Piovani, Federica Righi, Barbara Rossi, Marina Caterina Staccioli, Edoardo Cozzolino
APA, Harvard, Vancouver, ISO, and other styles
17

Leao, Sylvia Cardoso, Enrico Tortoli, Jean Paul Euzéby, and Maria Jesus Garcia. "Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus." International Journal of Systematic and Evolutionary Microbiology 61, no. 9 (September 1, 2011): 2311–13. http://dx.doi.org/10.1099/ijs.0.023770-0.

Full text
Abstract:
The names ‘Mycobacterium abscessus subsp. abscessus’ and ‘Mycobacterium abscessus subsp. massiliense’, proposed by Leao et al. (2009, J Clin Microbiol 47, 2691–2698), cannot be validly published. The purpose of this report is to provide a description in accordance with the Rules of the Bacteriological Code (1990 Revision). Moreover, the proposal of the name ‘Mycobacterium abscessus subsp. massiliense’ is contrary to Rule 38 and the correct name of this taxon, at the rank of subspecies, is Mycobacterium abscessus subsp. bolletii comb. nov. A description of Mycobacterium abscessus subsp. abscessus subsp. nov. and an emended description of Mycobacterium abscessus are also given.
APA, Harvard, Vancouver, ISO, and other styles
18

Adekambi, Toidi, Mohamed Sassi, Jakko van Ingen, and Michel Drancourt. "Reinstating Mycobacterium massiliense and Mycobacterium bolletii as species of the Mycobacterium abscessus complex." International Journal of Systematic and Evolutionary Microbiology 67, no. 8 (August 1, 2017): 2726–30. http://dx.doi.org/10.1099/ijsem.0.002011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Sassi, M., C. Bebeacua, M. Drancourt, and C. Cambillau. "The First Structure of a Mycobacteriophage, the Mycobacterium abscessus subsp. bolletii Phage Araucaria." Journal of Virology 87, no. 14 (May 15, 2013): 8099–109. http://dx.doi.org/10.1128/jvi.01209-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Damodar, Dhanur, David Chen, Nathaniel Jenkins, Nicholas Fort, and Seth D. Dodds. "Mycobacterium bolletii Osteomyelitis of the Metaphyseal Distal Radius Treated With Amikacin Antibiotic Beads." Journal of Hand Surgery 45, no. 12 (December 2020): 1188.e1–1188.e6. http://dx.doi.org/10.1016/j.jhsa.2020.01.014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Cheng, A., Y. C. Liu, M. L. Chen, C. C. Hung, Y. T. Tsai, W. H. Sheng, C. H. Liao, P. R. Hsueh, Y. C. Chen, and S. C. Chang. "Extrapulmonary infections caused by a dominant strain of Mycobacterium massiliense (Mycobacterium abscessus subspecies bolletii)." Clinical Microbiology and Infection 19, no. 10 (October 2013): E473—E482. http://dx.doi.org/10.1111/1469-0691.12261.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Holland, Peter C. "Prediction and surprise in human fear conditioning (Commentary on Bollet al.)." European Journal of Neuroscience 37, no. 5 (March 2013): 757. http://dx.doi.org/10.1111/ejn.12147.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Tan, Joon Liang, Yun Fong Ngeow, and Siew Woh Choo. "Support from Phylogenomic Networks and Subspecies Signatures for Separation of Mycobacterium massiliense from Mycobacterium bolletii." Journal of Clinical Microbiology 53, no. 9 (July 8, 2015): 3042–46. http://dx.doi.org/10.1128/jcm.00541-15.

Full text
Abstract:
Mycobacterium abscessussubspecies classification has important clinical implications. We used phylogenomic network and amino acid analyses to provide evidence for the separation ofMycobacterium bolletiiandMycobacterium massilienseinto two distinct subspecies which can potentially be differentiated rapidly by their protein signatures.
APA, Harvard, Vancouver, ISO, and other styles
24

Zelazny, A. M., J. M. Root, Y. R. Shea, R. E. Colombo, I. C. Shamputa, F. Stock, S. Conlan, et al. "Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii." Journal of Clinical Microbiology 47, no. 7 (May 6, 2009): 1985–95. http://dx.doi.org/10.1128/jcm.01688-08.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Pannarale, Luigi. "Questo matrimonio non s'ha da fare. Note a margine di una sentenza della corte costituzionale." SOCIOLOGIA DEL DIRITTO, no. 2 (November 2010): 171–76. http://dx.doi.org/10.3280/sd2010-002008.

Full text
Abstract:
L'autore commenta la recente sentenza della Corte costituzionale n. 138 del 14 aprile 2010, con la quale č stata ritenuta in parte inammissibile ed in parte infondata la questione di legittimitŕ costituzionale delle norme che non consentono alle persone di orientamento omosessuale di contrarre matrimonio con persone dello stesso sesso. A suo parere si č venuto a realizzare un non inconsueto scaricabarile: i giudici di merito hanno consegnato la patata bollente al giudice costituzionale, il quale a sua volta l'ha girata nelle mani del Parlamento che, nell'esercizio della sua piena discrezionalitŕ, potrŕ individuare le forme piů opportune di riconoscimento e di garanzia per le unioni omosessuali, restando riservato alla Consulta il piů limitato compito di intervenire a tutela di specifiche situazioni (come č giŕ avvenuto per la convivenza more uxorio), laddove sia riscontrabile la necessitŕ di un trattamento omogeneo tra la condizione della coppia coniugata e quella della coppia omosessuale, trattamento che la Corte puň garantire mediante il controllo di ragionevolezza. Era, infatti, impensabile che la Consulta osasse stravolgere il quadro normativo, assumendosi da sola la responsabilitŕ di estendere la facoltŕ di contrarre matrimonio anche alle coppie omosessuali, senza graduare in alcun modo trattamenti differenziati fra coppie omosessuali e coppie eterosessuali, come invece potrŕ fare il legislatore.
APA, Harvard, Vancouver, ISO, and other styles
26

Kim, H. Y., Y. Kook, Y. J. Yun, C. G. Park, N. Y. Lee, T. S. Shim, B. J. Kim, and Y. H. Kook. "Proportions of Mycobacterium massiliense and Mycobacterium bolletii Strains among Korean Mycobacterium chelonae-Mycobacterium abscessus Group Isolates." Journal of Clinical Microbiology 46, no. 10 (August 27, 2008): 3384–90. http://dx.doi.org/10.1128/jcm.00319-08.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Davidson, Rebecca M., Nabeeh A. Hasan, Vinicius Calado Nogueira de Moura, Rafael Silva Duarte, Mary Jackson, and Michael Strong. "Phylogenomics of Brazilian epidemic isolates of Mycobacterium abscessus subsp. bolletii reveals relationships of global outbreak strains." Infection, Genetics and Evolution 20 (December 2013): 292–97. http://dx.doi.org/10.1016/j.meegid.2013.09.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

de Moura, Vinicius Calado Nogueira, Marlei Gomes da Silva, Karen Machado Gomes, Fábrice Santana Coelho, Jorge Luiz Mello Sampaio, Fernanda Carvalho de Queiroz Mello, Maria Cristina da Silva Lourenço, Efigênia de Lourdes Teixeira Amorim, and Rafael Silva Duarte. "Phenotypic and molecular characterization of quinolone resistance in Mycobacterium abscessus subsp. bolletii recovered from postsurgical infections." Journal of Medical Microbiology 61, no. 1 (January 1, 2012): 115–25. http://dx.doi.org/10.1099/jmm.0.034942-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Wong, Y. L., S. W. Choo, J. L. Tan, C. S. Ong, K. P. Ng, and Y. F. Ngeow. "Draft Genome Sequence of Mycobacterium bolletii Strain M24, a Rapidly Growing Mycobacterium of Contentious Taxonomic Status." Journal of Bacteriology 194, no. 16 (July 27, 2012): 4475. http://dx.doi.org/10.1128/jb.00916-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

De Souza, Adjanny Estela Santos, Marlyara Vanessa Sampaio Marinho, Françoíse Gisela Gato Lopes, Victor de Lima Dias, Andreza Dantas Ribeiro, Brenda dos Santos Coutinho, and Audelaine Miranda Da Cruz. "Ocorrência de Micobactérias Não Tuberculosas (MNT) em uma unidade de referência do estado do Pará, Brasil." Saúde em Redes 6, no. 3 (April 30, 2021): 39–48. http://dx.doi.org/10.18310/2446-4813.2020v6n3p39-48.

Full text
Abstract:
Objetivo: Investigar a ocorrência de micobactérias não tuberculosas (MNT) em uma Unidade de Referência no Estado do Pará, Brasil e apresentar o perfil sociodemográfico e clínico dos pacientes acometidos. Métodos: foi realizada pesquisa descritiva retrospectiva com abordagem quantitativa por meio da coleta de dados no sistema de informação do laboratório que atua como referência para tuberculose nos vinte municípios da região Oeste do Pará no período de abril de 2011 a abril de 2017. Resultados: foram analisadas amostras de 513 pacientes com suspeita de TB, 09 (1,75%) tiveram diagnósco de MNT, sendo isolados M. avium, M. asiacum, M. intracellulare, M. paraensis e M. abscessus subsp. bolletii. Conclusão: evidencia-se o potencial das MNT em provocar doença semelhante à tuberculose, havendo a necessidade de melhorar a investigação etiológica para a detecção precoce das micobacterioses, afim de que sejam tomadas medidas adequadas de tratamento e prevenção da transmissão.
APA, Harvard, Vancouver, ISO, and other styles
31

Feenstra, P. A., D. S. Weaver, and Frantisek L. Eisinger. "A Study of Acoustic Resonance in a Staggered Tube Array." Journal of Pressure Vessel Technology 128, no. 4 (February 2, 2006): 533–40. http://dx.doi.org/10.1115/1.2349563.

Full text
Abstract:
Experimental laboratory research was performed to study the effect of test section width on the magnitude of acoustic resonance generated in a small pitch ratio staggered tube bank. Three different test section widths were studied: 505mm, 714mm, and 953mm. The results for acoustic resonance were compared to the tube bank data of Blevins and Bressler (1993, J. Sound Vib., 164(3), pp. 503–533), Ziada, Bolleter, and Chen (1984, ASME Symposium on Flow-Induced Vibrations, ASME, New York, Vol. 2, pp. 227–242); Ziada, Oengören, and Buhlmann (1989, J. Fluids and Struct., 3, pp. 293–324), and Fitzpatrick and Donaldson (1977, ASME J. Fluids Eng., 99, pp. 681–686). The present study showed that test-section width may be a significant factor in determining the maximum acoustic pressures generated by the flow. In particular, the simple relationship between maximum acoustic pressure and input energy parameter derived by Blevins and Bressler was not a reliable predictor for the array studied and will likely underpredict the maximum acoustic pressures in the lower modes of practical heat exchangers.
APA, Harvard, Vancouver, ISO, and other styles
32

Sabagh, Bruna Peres, Raphael Hirata Júnior, Amanda Fermiano da Cruz, Jéssica da Silva Souza, Monique Ramos de Oliveira Trugilho, and Maria Helena Simões Villas Bôas. "BIOFILMS FORMED BY MYCOBACTERIUM ABSCESSUS SUBSP. BOLLETII IN THE PRESENCE OF SUBINHIBITORY CONCENTRATIONS OF GLUTARALDEHYDE – A PUBLIC HEALTH ISSUE." Temas em Saúde 21, no. 5 (2021): 122–42. http://dx.doi.org/10.29327/213319.21.5-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Lee, Meng-Rui, Jen-Chung Ko, Sheng-Kai Liang, Shih-Wei Lee, David Hung-Tsang Yen, and Po-Ren Hsueh. "Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates." International Journal of Antimicrobial Agents 43, no. 5 (May 2014): 438–41. http://dx.doi.org/10.1016/j.ijantimicag.2014.02.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Teng, S. H., C. M. Chen, M. R. Lee, T. F. Lee, K. Y. Chien, L. J. Teng, and P. R. Hsueh. "Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Can Accurately Differentiate between Mycobacterium masilliense (M. abscessus subspecies bolletti) and M. abscessus (Sensu Stricto)." Journal of Clinical Microbiology 51, no. 9 (July 3, 2013): 3113–16. http://dx.doi.org/10.1128/jcm.01239-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Kim, Hee-Youn, Byoung Jun Kim, Yoonwon Kook, Yeo-Jun Yun, Jeong Hwan Shin, Bum-Joon Kim, and Yoon-Hoh Kook. "Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns." Microbiology and Immunology 54, no. 6 (March 8, 2010): 347–53. http://dx.doi.org/10.1111/j.1348-0421.2010.00221.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Choo, S. W., Y. L. Wong, J. L. Tan, C. S. Ong, G. J. Wong, K. P. Ng, and Y. F. Ngeow. "Annotated Genome Sequence of Mycobacterium massiliense Strain M154, Belonging to the Recently Created Taxon Mycobacterium abscessus subsp. bolletii comb. nov." Journal of Bacteriology 194, no. 17 (August 10, 2012): 4778. http://dx.doi.org/10.1128/jb.01043-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Vianna, Júlia S., Diana Machado, Ivy B. Ramis, Fábia P. Silva, Dienefer V. Bierhals, Michael Andrés Abril, Andrea von Groll, et al. "The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin." Antibiotics 8, no. 3 (September 18, 2019): 153. http://dx.doi.org/10.3390/antibiotics8030153.

Full text
Abstract:
The basis of drug resistance in Mycobacterium abscessus is still poorly understood. Nevertheless, as seen in other microorganisms, the efflux of antimicrobials may also play a role in M. abscessus drug resistance. Here, we investigated the role of efflux pumps in clarithromycin resistance using nine clinical isolates of M. abscessus complex belonging to the T28 erm(41) sequevar responsible for the inducible resistance to clarithromycin. The strains were characterized by drug susceptibility testing in the presence/absence of the efflux inhibitor verapamil and by genetic analysis of drug-resistance-associated genes. Efflux activity was quantified by real-time fluorometry. Efflux pump gene expression was studied by RT-qPCR upon exposure to clarithromycin. Verapamil increased the susceptibility to clarithromycin from 4- to ≥64-fold. The efflux pump genes MAB_3142 and MAB_1409 were found consistently overexpressed. The results obtained demonstrate that the T28 erm(41) polymorphism is not the sole cause of the inducible clarithromycin resistance in M. abscessus subsp. abscessus or bolletii with efflux activity providing a strong contribution to clarithromycin resistance. These data highlight the need for further studies on M. abscessus efflux response to antimicrobial stress in order to implement more effective therapeutic regimens and guidance in the development of new drugs against these bacteria.
APA, Harvard, Vancouver, ISO, and other styles
38

Rodríguez-Cerdeira, Carmen, Rigoberto Hernández-Castro, Carlos Daniel Sánchez-Cárdenas, Roberto Arenas, Alejandro Meza-Robles, Sonia Toussaint-Care, Carlos Atoche-Diéguez, and Erick Martínez-Herrera. "Atypical Mycobacteriosis Due to Mycobacterium abscessus subsp. massiliense: Our Experince." Pathogens 11, no. 12 (November 23, 2022): 1399. http://dx.doi.org/10.3390/pathogens11121399.

Full text
Abstract:
Background: Members of Micobacterium. abscessus complex comprises three subspecies (M. abscessus subsp. Abscessus, M. abscessus subsp. Bolletii, and M. abscessus subsp. Massiliense) and are a rapid-growing nontuberculous mycobacteria present in different aquatic habitats and soil. It often causes a wide spectrum of infections involving pulmonary infections, surgical wound infections, and infections related to mesotherapy, catheters, hemodialysis devices, endocarditis, and disseminated infections in immunocompromised individuals. Methods: In this article we comment on the most relevant aspects of nine patients with skin lesions caused by M. abscessus subsp. massiliense infection. Clinical characteristics, histopathology, and molecular identification were performed. Results: The patients in the clinical cases presented a history of trauma, tattoos, and physical therapy techniques. The most common treatments were minocycline and clindamycin, doxycycline, ceftriaxone, cephalexin, moxifloxacin, rifampicin, and trimethoprim-sulfamethoxazole. The evolution of the treated patients was acceptable, except for one patient, who showed a partial improvement. M. massiliense were identified in all clinical cases using a species-specific PCR. Conclusion: Our series consisted of nine cases of skin biopsies recorded in different years; for this reason, we do not have all the data necessary for a complete description, in particular in four cases, causing limitations in the manuscript, especially in the therapy used and the evolution of patients due to lack of follow-up.
APA, Harvard, Vancouver, ISO, and other styles
39

Viana-Niero, C., K. V. B. Lima, M. L. Lopes, M. C. da Silva Rabello, L. R. Marsola, V. C. R. Brilhante, A. M. Durham, and S. C. Leao. "Molecular Characterization of Mycobacterium massiliense and Mycobacterium bolletii in Isolates Collected from Outbreaks of Infections after Laparoscopic Surgeries and Cosmetic Procedures." Journal of Clinical Microbiology 46, no. 3 (January 3, 2008): 850–55. http://dx.doi.org/10.1128/jcm.02052-07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Hinková, A., Z. Bubník, V. Pour, S. Henke, and P. Kadlec. "Application of cross-flow ultrafiltration on inorganic membranes in purification of food materials." Czech Journal of Food Sciences 23, No. 3 (November 15, 2011): 103–10. http://dx.doi.org/10.17221/3378-cjfs.

Full text
Abstract:
This paper brings data on ultrafiltration on inorganic membranes (MEMBRALOX, France, mean pore size 20 and 100&nbsp;nm, 0.8 m long, filtration area 0.2 m<sup>2</sup>), which were used for the purification of different liquid materials from the food industry; in particular egg blend, amaranth starch suspension, and caramel (i.e. natural colorant). The ultrafiltration was carried out on a pilot plant filtration unit TIA (Bollene, France), cross-flow permeate fluxes being measured at first. Using the experimental data, mathematical models describing membrane fouling were suggested. The obtained permeate steady-state fluxes (40 l/h/m<sup>2</sup> for amaranth starch solution, 20 l/h/m<sup>2</sup> for egg blend and 5&ndash;30&nbsp;l/h/m<sup>2</sup> for caramel) depended partially on the filtration temperature (15&ndash;17&deg;C for egg blend, 40&deg;C for amaranth, and 50&ndash;70&deg;C for caramel) but mostly on the character of the medium filtered. &nbsp;
APA, Harvard, Vancouver, ISO, and other styles
41

Matsumoto, Cristianne Kayoko, Erica Chimara, Jesus Pais Ramos, Carlos Eduardo Dias Campos, Paulo Cesar de Souza Caldas, Karla Valeria Batista Lima, Maria Luiza Lopes, Rafael Silva Duarte, and Sylvia Cardoso Leão. "Rapid tests for the detection of the Mycobacterium abscessus subsp. bolletii strain responsible for an epidemic of surgical-site infections in Brazil." Memórias do Instituto Oswaldo Cruz 107, no. 8 (December 2012): 969–77. http://dx.doi.org/10.1590/s0074-02762012000800002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Leão, Sylvia Cardoso, Cristianne Kayoko Matsumoto, Adriana Carneiro, Rommel Thiago Ramos, Christiane Lourenço Nogueira, James Daltro Lima Junior, Karla Valéria Lima, et al. "The Detection and Sequencing of a Broad-Host-Range Conjugative IncP-1β Plasmid in an Epidemic Strain of Mycobacterium abscessus subsp. bolletii." PLoS ONE 8, no. 4 (April 2, 2013): e60746. http://dx.doi.org/10.1371/journal.pone.0060746.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Nie, Wenjuan, Hongfei Duan, Hairong Huang, Yu Lu, Dapeng Bi, and Naihui Chu. "Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics." International Journal of Infectious Diseases 25 (August 2014): 170–74. http://dx.doi.org/10.1016/j.ijid.2014.02.014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Tortoli, Enrico, Thomas A. Kohl, Barbara A. Brown-Elliott, Alberto Trovato, Sylvia Cardoso Leão, Maria Jesus Garcia, Sruthi Vasireddy, et al. "Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov." International Journal of Systematic and Evolutionary Microbiology 66, no. 11 (November 1, 2016): 4471–79. http://dx.doi.org/10.1099/ijsem.0.001376.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Yoshida, Shiomi, Kazunari Tsuyuguchi, Katsuhiro Suzuki, Motohisa Tomita, Masaji Okada, Seiji Hayashi, Tomotada Iwamoto, and Hajime Saito. "Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents." International Journal of Antimicrobial Agents 42, no. 3 (September 2013): 226–31. http://dx.doi.org/10.1016/j.ijantimicag.2013.04.029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Bastian, Sylvaine, Nicolas Veziris, Anne-Laure Roux, Florence Brossier, Jean-Louis Gaillard, Vincent Jarlier, and Emmanuelle Cambau. "Assessment of Clarithromycin Susceptibility in Strains Belonging to theMycobacterium abscessusGroup byerm(41) andrrlSequencing." Antimicrobial Agents and Chemotherapy 55, no. 2 (December 6, 2010): 775–81. http://dx.doi.org/10.1128/aac.00861-10.

Full text
Abstract:
ABSTRACTClarithromycin was the drug of choice forMycobacterium abscessusinfections until inducible resistance due toerm(41) was described. BecauseM. abscessuswas split intoM. abscessussensu stricto,Mycobacterium massiliense, andMycobacterium bolletii, we looked forerm(41) in the three species and determined their clarithromycin susceptibility levels. Ninety strains were included: 87 clinical strains from cystic fibrosis patients (61%) and others (39%), representing 43M. abscessus, 30M. massiliense, and 14M. bolletiistrains identified on a molecular basis, and 3 reference strains. Clarithromycin and azithromycin MICs were determined by broth microdilution and Etest with a 14-day incubation period. Mutations inrrl(23S rRNA gene) known to confer acquired clarithromycin resistance were also sought.erm(41) was detected in all strains but with two deletions in allM. massiliensestrains. These strains were indeed susceptible to clarithromycin (MIC90of 1 μg/ml) except for four strains withrrlmutations.M. abscessusstrains harbored an intacterm(41) but had a T/C polymorphism at the 28th nucleotide: T28 strains (Trp10 codon) demonstrated inducible clarithromycin resistance (MIC90of >16 μg/ml), while C28 strains (Arg10) were susceptible (MIC90of 2 μg/ml) except for two strains withrrlmutations.M. bolletiistrains haderm(41) sequences similar to the sequence of the T28M. abscessusgroup, associated with inducible clarithromycin resistance (MIC90of >16 μg/ml).erm(41) sequences appeared species specific within theM. abscessusgroup and were fully concordant with clarithromycin susceptibility whenerm(41) sequencing was associated with detection ofrrlmutations. Clarithromycin-resistant strains, including the sixrrlmutants, were more often isolated in cystic fibrosis patients, but this was not significantly associated with a previous treatment.
APA, Harvard, Vancouver, ISO, and other styles
47

Kwak, Nakwon, Margareth Pretti Dalcolmo, Charles L. Daley, Geoffrey Eather, Regina Gayoso, Naoki Hasegawa, Byung Woo Jhun, et al. "Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis." European Respiratory Journal 54, no. 1 (March 17, 2019): 1801991. http://dx.doi.org/10.1183/13993003.01991-2018.

Full text
Abstract:
Treatment of Mycobacterium abscessus pulmonary disease (MAB-PD), caused by M. abscessus subsp. abscessus, M. abscessus subsp. massiliense or M. abscessus subsp. bolletii, is challenging.We conducted an individual patient data meta-analysis based on studies reporting treatment outcomes for MAB-PD to clarify treatment outcomes for MAB-PD and the impact of each drug on treatment outcomes. Treatment success was defined as culture conversion for ≥12 months while on treatment or sustained culture conversion without relapse until the end of treatment.Among 14 eligible studies, datasets from eight studies were provided and a total of 303 patients with MAB-PD were included in the analysis. The treatment success rate across all patients with MAB-PD was 45.6%. The specific treatment success rates were 33.0% for M. abscessus subsp. abscessus and 56.7% for M. abscessus subsp. massiliense. For MAB-PD overall, the use of imipenem was associated with treatment success (adjusted odds ratio (aOR) 2.65, 95% CI 1.36–5.10). For patients with M. abscessus subsp. abscessus, the use of azithromycin (aOR 3.29, 95% CI 1.26–8.62), parenteral amikacin (aOR 1.44, 95% CI 1.05–1.99) or imipenem (aOR 7.96, 95% CI 1.52–41.6) was related to treatment success. For patients with M. abscessus subsp. massiliense, the choice among these drugs was not associated with treatment outcomes.Treatment outcomes for MAB-PD are unsatisfactory. The use of azithromycin, amikacin or imipenem was associated with better outcomes for patients with M. abscessus subsp. abscessus.
APA, Harvard, Vancouver, ISO, and other styles
48

Bosi, Claude, Anne Davin-Regli, Charleric Bornet, Monique Mallea, Jean-Marie Pages, and Claude Bollet. "Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone." Journal of Clinical Microbiology 37, no. 7 (1999): 2165–69. http://dx.doi.org/10.1128/jcm.37.7.2165-2169.1999.

Full text
Abstract:
The aim of this study was to determine the distribution in France of the Enterobacter aerogenes prevalent clone isolated in the hospitals of the Marseille area (A. Davin-Regli, D. Monnet, P. Saux, C. Bosi, R. Charrel, A. Barthelemy, and C. Bollet, J. Clin. Microbiol. 34:1474–1480, 1996). A total of 123 E. aerogenes isolates were collected from 23 hospital laboratories and analyzed by random amplification of polymorphic DNA and enterobacterial repetitive intergenic consensus-PCR to determine their epidemiological relatedness. Molecular typing revealed that 21 of the 23 laboratories had isolated this prevalent clone harboring the plasmid encoding for extended-spectrum β-lactamase of the TEM-24 type. Most isolates were susceptible only to imipenem and gentamicin. Their dissemination seems to be clonal and was probably the result of the general use of broad-spectrum cephalosporins and quinolones. Four isolates showed an alteration of their outer membrane proteins, causing decrease of susceptibility to third-generation cephalosporins and imipenem and leading to the critical situation of having no alternative therapeutic. The large dissemination of the E. aerogenesprevalent clone probably results from its good adaptation to the antibiotics administered in France and the hospital environment, particularly in intensive care units.
APA, Harvard, Vancouver, ISO, and other styles
49

Deakin, Charles D., and Graham W. Petley. "Re: Wampler D, Kharod C, Bolleter S, Burkett A, Gabehart C, Manifold C. A randomized control hands-on defibrillation study – Barrier use evaluation. Resuscitation. 2016." Resuscitation 105 (August 2016): e13. http://dx.doi.org/10.1016/j.resuscitation.2016.05.030.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Nash, Kevin A., Barbara A. Brown-Elliott, and Richard J. Wallace. "A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae." Antimicrobial Agents and Chemotherapy 53, no. 4 (January 26, 2009): 1367–76. http://dx.doi.org/10.1128/aac.01275-08.

Full text
Abstract:
ABSTRACT Mycobacterium abscessus infections tend to respond poorly to macrolide-based chemotherapy, even though the organisms appear to be susceptible to clarithromycin. Circumstantial evidence suggested that at least some M. abscessus isolates might be inducibly resistant to macrolides. Thus, the purpose of this study was to investigate the macrolide phenotype of M. abscessus clinical isolates. Inducible resistance to clarithromycin (MIC > 32 μg/ml) was found for 7 of 10 clinical isolates of M. abscessus previously considered susceptible; the remaining 3 isolates were deemed to be susceptible (MIC ≤ 0.5 μg/ml). Inducible resistance was conferred by a novel erm gene, erm(41), which was present in all 10 isolates and in an isolate of Mycobacterium bolletii (M. abscessus type II). However, the erm(41) alleles were nonfunctional in the three susceptible M. abscessus isolates. No evidence of erm(41) was found in Mycobacterium chelonae, and an isolate of Mycobacterium massiliense appeared to be an erm(41) deletion mutant. Expression of erm(41) in M. abscessus conferred resistance to clarithromycin and erythromycin and the ketolide HMR3004. However, this species was found to be intrinsically resistant, independent of erm(41), to clindamycin, quinupristin (streptogramin B), and telithromycin. The ability to confer resistance to clindamycin and telithromycin, but not quinupristin, was demonstrated by expressing erm(41) in Maycobacterium smegmatis. Exposure of M. abscessus to the macrolide-lincosamide-streptogramin B-ketolide agents increased the levels of erm(41) mRNA 23- to 250-fold within 24 h. The inducible macrolide resistance phenotype of some M. abscessus isolates may explain the lack of efficacy of macrolide-based chemotherapy against this organism.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Bollette' for other source types:
Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography